Ostéonécrose des maxillaires liée aux bisphosphonates et denosumab : épidémiologie, diagnostic et traitement

Aapro, 2008, Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel, Ann Oncol, 19, 420, 10.1093/annonc/mdm442

Sigua-Rodriguez, 2014, Bisphosphonate-related osteonecrosis of the jaw: a review of the literature, Int J Dent, 2014, 192320, 10.1155/2014/192320

Kühl, 2012, Bisphosphonate-related osteonecrosis of the jaws – a review, Oral Oncol, 48, 938, 10.1016/j.oraloncology.2012.03.028

Tubiana-Hulin, 2009, Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis, Crit Rev Oncol Hematol, 71, 12, 10.1016/j.critrevonc.2008.10.009

Lo, 2010, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure, J Oral Maxillofac Surg, 68, 243, 10.1016/j.joms.2009.03.050

Khan, 2015, International task force on osteonecrosis of the jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus, J Bone Miner Res, 30, 3, 10.1002/jbmr.2405

Société française de stomatologie, chirurgie maxillofaciale et chirurgie orale, 2013

Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1

Pillon, 2014, Bisphosphonates et ostéonécrose des mâchoires, Actual Pharm, 53, 48

Reid, 2012, Epidemiology and pathogenesis of osteonecrosis of the jaw, Nat Rev Rheumatol, 8, 90, 10.1038/nrrheum.2011.181

Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws – 2009 update, J Oral Maxillofac Surg, 67, 2

Ruggiero, 2014, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update, J Oral Maxillofac Surg, 72, 1938, 10.1016/j.joms.2014.04.031

Khosla, 2007, American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research, J Bone Miner Res, 22, 1479, 10.1359/jbmr.0707onj

Khan, 2008, Canadian Association of Oral and Maxillofacial Surgeons. Canadian consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw, J Rheumatol, 35, 1391

AFSSAPS, 2007

Hinchy, 2013, Osteonecrosis of the jaw – prevention and treatment strategies for oral health professionals, Oral Oncol, 49, 878, 10.1016/j.oraloncology.2013.06.008

Facon, 2008, [Osteonecrosis of the jaw and bisphophonates in oncology], Bull Cancer (Paris), 95, 413

Clézardin, 2000, Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis, J Bone Spine Rev Rhum, 67, 22

Russell, 2007, Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy, Ann N Y Acad Sci, 1117, 209, 10.1196/annals.1402.089

Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658

Robert, 2015, [Bisphosphonates as new anticancer agents?], Bull Cancer (Paris), 102, 297

Brown-Glaberman, 2012, Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors, Biol Targets Ther, 6, 89

Kyrgidis, 2011, Denosumab-related osteonecrosis of the jaws, Osteoporos Int, 22, 369, 10.1007/s00198-010-1177-6

Magremanne, 2014, Diagnostic étiologique des ostéonécroses maxillomandibulaires, ostéites à bisphosphonates et ostéoradionécroses exceptées, Rev Stomatol Chir Maxillofac, 115, e1

Fizazi, 2011, Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study, Lancet, 377, 813, 10.1016/S0140-6736(10)62344-6

Olate, 2014, Osteonecrosis of the jaw in patient with denosumab therapy, Int J Clin Exp Med, 7, 3707

Lipton, 2012, Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials, Eur J Cancer Oxf Engl 1990, 48, 3082

Silverman, 2009, Osteonecrosis of the jaw and the role of bisphosphonates: a critical review, Am J Med, 122, S33, 10.1016/j.amjmed.2008.12.005

Rasmusson, 2014, Bisphosphonate-associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment, Int J Dent, 2014, 471035, 10.1155/2014/471035

Bocanegra-Pérez, 2012, Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw, Int J Oral Maxillofac Surg, 41, 1410, 10.1016/j.ijom.2012.04.020

Franco-Pretto, 2014, Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings, Oral Surg Oral Med Oral Pathol Oral Radiol, 118, 408, 10.1016/j.oooo.2014.04.017

Otto, 2012, Bisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatment, J Cranio-Maxillo-Fac Surg, 40, 303, 10.1016/j.jcms.2011.05.003

Wanrong, 2013, CONDOR Collaborative Group. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN, Tex Dent J, 130, 299

Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670

Hoff, 2008, Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates, J Bone Miner Res, 23, 826, 10.1359/jbmr.080205

Watters, 2013, Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients, Oral Surg Oral Med Oral Pathol Oral Radiol, 115, 192, 10.1016/j.oooo.2012.05.017

Altay, 2014, Low-level laser therapy supported surgical treatment of bisphosphonate-related osteonecrosis of jaws: a retrospective analysis of 11 cases, Photomed Laser Surg, 32, 468, 10.1089/pho.2014.3742

Barba-Recreo, 2014, Zoledronic acid-related osteonecrosis of the jaws. Experimental model with dental extractions in rats, J Cranio-Maxillo-Fac Surg, 42, 744, 10.1016/j.jcms.2013.11.005

Marx, 2005, Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010

Vahtsevanos, 2009, Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw, J Clin Oncol, 27, 5356, 10.1200/JCO.2009.21.9584

Diz, 2012, Denosumab-related osteonecrosis of the jaw, J Am Dent Assoc 1939, 143, 981, 10.14219/jada.archive.2012.0323

Schubert, 2012, The saxon bisphosphonate register – therapy and prevention of bisphosphonate-related osteonecrosis of the jaws, Oral Oncol, 48, 349, 10.1016/j.oraloncology.2011.11.004

McLeod, 2010, Management of patients at risk of osteoradionecrosis: results of survey of dentists and oral & maxillofacial surgery units in the United Kingdom, and suggestions for best practice, Br J Oral Maxillofac Surg, 48, 301, 10.1016/j.bjoms.2009.06.128

Damm, 2013, Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays, Gen Dent, 61, 33

Saia, 2010, Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction, J Oral Maxillofac Surg, 68, 797, 10.1016/j.joms.2009.10.026

Mozzati, 2013, Tooth extraction in osteoporotic patients taking oral bisphosphonates, Osteoporos Int, 24, 1707, 10.1007/s00198-012-2239-8

Vescovi, 2013, Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy, Med Oral Patol Oral Cir Bucal, 18, e680, 10.4317/medoral.18812

Van den Wyngaert, 2009, Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome, Ann Oncol, 20, 331, 10.1093/annonc/mdn630

Lerman, 2013, Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes, Oral Oncol, 49, 977, 10.1016/j.oraloncology.2013.05.012

Holzinger, 2013, Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs), Oral Oncol, 49, 66, 10.1016/j.oraloncology.2012.07.008

Rupel, 2014, A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ), Oral Oncol, 50, 1049, 10.1016/j.oraloncology.2014.08.016

Hellstein, 2011, J Am Dent Assoc 1939, 142, 1243, 10.14219/jada.archive.2011.0108

Ferlito, 2012, Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases, Br J Oral Maxillofac Surg, 50, 425, 10.1016/j.bjoms.2011.08.004

Lu, 2014, Retrospective analysis of 27 cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or non-surgically, J Dent Sci, 9, 185, 10.1016/j.jds.2013.03.004

Hindawi, 2011, Non-surgical management of stage 3 biphosphonate-related oroantral fistula, Br J Oral Maxillofac Surg, 49, e16, 10.1016/j.bjoms.2010.09.009

Shintani, 2015, Bisphosphonate-related osteonecrosis of the jaw successfully treated with surgical resection and its histopathological features: a long-term follow-up report, J Oral Maxillofac Surg Med Pathol, 27, 283, 10.1016/j.ajoms.2014.02.004

Vercruysse, 2014, Outcomes of osseous free flap reconstruction in stage III bisphosphonate-related osteonecrosis of the jaw: systematic review and a new case series, J Cranio-Maxillo-Fac Surg, 42, 377, 10.1016/j.jcms.2014.01.005

Otto, 2013, Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection, J Cranio-Maxillo-Fac Surg, 41, 694, 10.1016/j.jcms.2013.05.038

Montebugnoli, 2007, Biphosphonate-associated osteonecrosis can be controlled by non-surgical management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, 473, 10.1016/j.tripleo.2007.01.008

Lee, 2014, Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws, J Formos Med Assoc Taiwan Yi Zhi, 113, 166, 10.1016/j.jfma.2012.04.010

McLeod, 2011, Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw, Br J Oral Maxillofac Surg, 49, 335, 10.1016/j.bjoms.2010.08.005

Song, 2008, A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment, Curr Ther Res Clin Exp, 69, 356, 10.1016/j.curtheres.2008.08.003

Cheung, 2010, Teriparatide therapy for alendronate-associated osteonecrosis of the jaw, N Engl J Med, 363, 2473, 10.1056/NEJMc1002684

Chtioui, 2011, Teriparatide therapy for osteonecrosis of the jaw, N Engl J Med, 364, 1081, 10.1056/NEJMc1100730

Vescovi, 2014, Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw, Int J Dent, 2014, 107690, 10.1155/2014/107690

Ripamonti, 2011, Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I–II study, Oral Oncol, 47, 185, 10.1016/j.oraloncology.2011.01.002

Cella, 2011, Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate-related osteonecrosis of the jaw, Head Face Med, 7, 16, 10.1186/1746-160X-7-16

Epstein, 2010, Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 110, 593, 10.1016/j.tripleo.2010.05.067

Freiberger, 2012, What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics, J Oral Maxillofac Surg, 70, 1573, 10.1016/j.joms.2012.04.001

Andriani, 2012, Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study, Blood Cancer J, 2, e62, 10.1038/bcj.2012.9

Mozzati, 2012, Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases, Oral Oncol, 48, 469, 10.1016/j.oraloncology.2011.12.004

Vescovi, 2010, Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT), Lasers Med Sci, 25, 101, 10.1007/s10103-009-0687-y

Vescovi, 2012, Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients, J Oral Pathol Med, 41, 214, 10.1111/j.1600-0714.2011.01091.x

Martins, 2012, Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study, Oral Oncol, 48, 79, 10.1016/j.oraloncology.2011.08.010

Patel, 2012, Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines, Oral Dis, 18, 625, 10.1111/j.1601-0825.2012.01911.x

Bedogni, 2012, Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ), Oral Dis, 18, 621, 10.1111/j.1601-0825.2012.01903.x